# CLINICOS — FACIAL ANALYSIS SPECIFICATION
**Document:** `CLINICOS_FACIAL_ANALYSIS_SPEC.md`  
**Status:** Target / Authoritative Facial Analysis Specification  
**Purpose:** Define the target architecture, safety model, data model, AI workflow, image-processing pipeline, reporting model, evaluation framework, privacy controls, and integration requirements for facial and skin image analysis in Clinicos.  
**Applies To:** Facial Analysis, Skin Analysis, Patient Intelligence, Doctor Copilot, Secretary Copilot, Medical Safety, Reporting, AI Agents, Knowledge, Analytics, and future computer-vision capabilities.  
**Priority:** Critical
---
# 1. Purpose
Facial Analysis is a major AI capability of Clinicos.
The purpose of Facial Analysis is to transform patient-provided facial images into structured, clinically useful, aesthetically relevant, and safety-controlled observations.
The system may analyze:
- visible facial characteristics
- skin appearance
- image quality
- asymmetry
- visible texture
- pigmentation appearance
- redness appearance
- visible lines
- visible pores
- acne-like lesions
- visible scars
- visible vascular appearance
- facial proportions
- observable aesthetic characteristics
However, Clinicos must clearly distinguish between:
```text
Image Observation
Clinical Interpretation
Medical Diagnosis
Treatment Recommendation

These are not equivalent.

⸻

2. Core Principle

Facial Analysis must not be designed as:

Image
    ↓
AI
    ↓
Diagnosis

The preferred architecture is:

Image
    ↓
Image Validation
    ↓
Image Quality Assessment
    ↓
Face Detection
    ↓
Region Detection
    ↓
Feature Extraction
    ↓
Visible Observation
    ↓
Confidence Assessment
    ↓
Medical Safety Review
    ↓
Structured Analysis
    ↓
Optional Educational Guidance
    ↓
Human Review When Required

⸻

3. Safety Principle

The system must never imply that visual analysis alone is equivalent to a clinical examination.

Facial Analysis should communicate:

What is visibly observed
What is uncertain
What cannot be determined from the image
When professional evaluation is appropriate

The system must avoid presenting uncertain visual observations as definitive medical diagnoses.

⸻

4. Analysis Boundary

Facial Analysis may identify visible patterns.

It should not automatically claim:

Definitive Diagnosis
Histopathological Diagnosis
Definitive Cancer Diagnosis
Definitive Infection Diagnosis
Definitive Allergy Diagnosis
Definitive Autoimmune Diagnosis
Definitive Medication Reaction
Definitive Treatment Necessity

unless an explicitly validated clinical workflow supports such a capability.

⸻

5. Facial Analysis Goals

The target system should provide:

1. Image quality assessment
2. Facial landmark detection
3. Region segmentation
4. Visible feature detection
5. Structured observations
6. Confidence estimates
7. Comparison across time
8. Patient-friendly explanation
9. Clinician-oriented analysis
10. Safety escalation
11. Optional report generation
12. Longitudinal tracking

⸻

6. Non-Goals

Facial Analysis should not initially attempt to:

* replace a dermatologist
* replace a plastic surgeon
* replace an in-person examination
* independently prescribe medication
* independently diagnose serious disease
* independently determine treatment eligibility
* guarantee treatment outcomes
* guarantee cosmetic outcomes

⸻

7. Analysis Modes

The system should support multiple analysis modes.

Recommended modes:

BASIC_SKIN_ANALYSIS
AESTHETIC_ANALYSIS
FACIAL_PROPORTION_ANALYSIS
BEFORE_AFTER_COMPARISON
LONGITUDINAL_ANALYSIS
CLINICIAN_REVIEW
PATIENT_EDUCATION

The exact mode determines which models, rules, and outputs are permitted.

⸻

8. User Types

Facial Analysis may be used by:

PATIENT
SECRETARY
DOCTOR
OWNER
MANAGER
ADMIN

Permissions must determine:

* who can upload images
* who can view images
* who can view analysis
* who can export reports
* who can share results
* who can delete images

⸻

9. Patient-Facing Analysis

Patient-facing analysis should prioritize:

Clarity
Safety
Uncertainty
Non-diagnostic Language
Actionability
Privacy

Example:

Visible skin texture appears uneven in the provided image.
This image alone cannot determine the underlying medical cause.

⸻

10. Clinician-Facing Analysis

Clinician-facing analysis may expose more structured detail.

Example:

Region:
Bilateral cheeks
Observation:
Visible erythematous appearance
Confidence:
0.78
Image Quality:
Good
Clinical Interpretation:
Requires professional assessment

The exact interpretation must remain appropriately qualified.

⸻

11. Image Input

Supported image formats may include:

JPEG
PNG
WEBP
HEIC

The exact supported formats depend on the implementation environment.

⸻

12. Image Upload Validation

Before analysis, validate:

File Type
File Size
Image Dimensions
Image Integrity
Encoding
Metadata
Corruption

Invalid images should be rejected safely.

⸻

13. Image Quality

Image quality is a critical component.

The system should evaluate:

Resolution
Sharpness
Brightness
Contrast
Exposure
Blur
Noise
Occlusion
Face Visibility
Angle
Distance
Color Consistency

⸻

14. Image Quality Score

The system may produce a structured score:

{
  "overall_score": 0.87,
  "sharpness": 0.92,
  "lighting": 0.81,
  "face_visibility": 0.95,
  "occlusion": 0.90
}

Scores should be treated as quality indicators rather than medical measurements.

⸻

15. Minimum Quality Threshold

If the image does not meet the required quality threshold:

Do Not Analyze

Instead:

Request Better Image

⸻

16. Image Retry Flow

The system should provide actionable retry instructions.

Example:

Please upload another photo with:
- brighter, even lighting
- no beauty filter
- no sunglasses
- no mask
- face centered
- camera at approximately eye level
- minimal motion blur

⸻

17. Image Quality Failure

Possible states:

IMAGE_TOO_BLURRY
IMAGE_TOO_DARK
IMAGE_TOO_BRIGHT
FACE_NOT_FOUND
FACE_PARTIALLY_VISIBLE
MULTIPLE_FACES
EXCESSIVE_OCCLUSION
LOW_RESOLUTION
UNSUPPORTED_FORMAT
IMAGE_CORRUPTED

⸻

18. Beauty Filters

Beauty filters may significantly distort facial analysis.

The system should attempt to detect obvious:

Beauty Filters
Skin Smoothing
Face Reshaping
Artificial Makeup
Extreme Color Correction

When detected:

Analysis Confidence Must Decrease

and the system may request an unfiltered image.

⸻

19. Makeup

Makeup can alter visible features.

The system should consider:

Foundation
Concealer
Heavy Contouring
Artificial Blush
Artificial Highlight

when evaluating skin appearance.

The system should avoid overconfident conclusions when makeup significantly affects visibility.

⸻

20. Lighting

Uneven lighting can create false observations.

The system should identify:

Strong Shadows
Directional Lighting
Color Cast
Overexposure
Underexposure

and reduce confidence when necessary.

⸻

21. Camera Angle

Facial geometry analysis should account for:

Yaw
Pitch
Roll
Camera Distance
Perspective Distortion

Poor angle should reduce confidence.

⸻

22. Multiple Faces

If multiple faces are detected:

Do Not Guess

The system should either:

* request a single-person image
* allow explicit face selection
* reject the image

depending on the workflow.

⸻

23. Face Detection

The pipeline should detect:

Face Bounding Box
Facial Landmarks
Face Orientation
Visible Regions

Possible regions:

Forehead
Glabella
Eyes
Periorbital Area
Nose
Cheeks
Nasolabial Region
Lips
Chin
Jawline
Neck

⸻

24. Facial Landmarks

Landmark detection may support:

Eye Corners
Eyebrows
Nose
Mouth
Chin
Jawline
Facial Contour

Landmarks should be treated as computational geometry rather than clinical truth.

⸻

25. Facial Region Mapping

The system should map observations to anatomical or aesthetic regions.

Example:

{
  "region": "left_cheek",
  "observation": "visible_pigmentation",
  "confidence": 0.81
}

⸻

26. Skin Observation Categories

Possible visible categories include:

TEXTURE
PIGMENTATION
REDNESS
VISIBLE_PORES
VISIBLE_LINES
ACNE_LIKE_APPEARANCE
SCAR_LIKE_APPEARANCE
DRYNESS_LIKE_APPEARANCE
OILINESS_LIKE_APPEARANCE
SWELLING_LIKE_APPEARANCE

These labels should remain appropriately descriptive.

⸻

27. Terminology Principle

Prefer observational language such as:

visible redness
visible pigmentation
uneven texture
appearance of fine lines

instead of unsupported diagnostic statements such as:

rosacea
melasma
eczema
infection

unless the clinical workflow explicitly supports validated diagnostic reasoning.

⸻

28. Observation Object

A facial observation may contain:

id
analysis_id
region
category
description
severity
confidence
visibility
evidence
model_version
created_at

⸻

29. Confidence

Each AI-derived observation should have a confidence representation.

Example:

{
  "confidence": 0.82
}

Confidence must not be interpreted as probability of disease unless explicitly calibrated for that task.

⸻

30. Confidence Calibration

Confidence values should be evaluated against labeled datasets.

A raw model score must not automatically be exposed to patients as a clinical probability.

⸻

31. Severity

Where appropriate, observations may have relative severity:

MINIMAL
MILD
MODERATE
MARKED

Severity should be defined separately for each observation category.

⸻

32. Severity Limitations

Severity labels should not imply medical urgency unless validated.

For example:

MODERATE_VISIBLE_PIGMENTATION

does not mean:

MODERATE_DISEASE

⸻

33. Symmetry Analysis

The system may evaluate visible facial symmetry.

Potential measurements:

Left-Right Landmark Differences
Contour Differences
Eye Position Differences
Mouth Position Differences
Jawline Differences

These should be treated as geometric observations.

⸻

34. Facial Proportion Analysis

The system may calculate relative proportions such as:

Upper Face
Mid Face
Lower Face

and ratios involving landmarks.

These measurements should be normalized for:

Head Pose
Perspective
Image Scale
Camera Distance

⸻

35. Aesthetic Interpretation

Aesthetic interpretation must be clearly separated from objective measurements.

Example:

Measurement:
Lower-face width ratio = X
Interpretation:
The measured geometry may contribute to a perceived broader lower-face appearance.

The second statement is an interpretation, not a direct measurement.

⸻

36. No Universal Beauty Score

Clinicos should avoid presenting a simplistic:

Beauty Score = 87/100

as an objective measure of attractiveness.

Such scores may be misleading, culturally biased, and clinically unhelpful.

⸻

37. Optional Aesthetic Scoring

If an aesthetic score is ever introduced, it must be:

* clearly labeled subjective
* configurable
* explainable
* validated
* culturally cautious
* never presented as medical truth

⸻

38. Skin Feature Detection

Potential visual features:

Pigmented Areas
Red Areas
Texture Irregularity
Visible Lines
Pore Appearance
Acne-Like Lesions
Scar-Like Areas
Uneven Tone
Shine
Dry-Looking Areas

⸻

39. Lesion Detection Boundary

Lesion detection must be carefully controlled.

The system may identify:

Visible lesion-like region

but should not automatically claim:

Benign
Malignant
Cancerous
Precancerous

without a validated clinical diagnostic workflow.

⸻

40. High-Risk Visual Findings

If the model detects a potentially concerning visible finding, the system may trigger:

MEDICAL_REVIEW_RECOMMENDED

rather than generating a diagnosis.

⸻

41. Medical Escalation

Potential escalation triggers may include:

Unusual Visible Lesion
Rapidly Changing Appearance Reported by Patient
Bleeding Lesion Reported by Patient
Ulceration-Like Appearance
Severe Swelling
Possible Acute Reaction
Severe Asymmetry

These signals require cautious handling.

⸻

42. Emergency Boundaries

Facial Analysis should not be the sole mechanism for emergency triage.

If user-reported symptoms indicate possible emergency conditions, the Medical Safety layer should take precedence over image analysis.

⸻

43. Medical Safety Agent Integration

Facial Analysis must integrate with the Medical Safety Agent.

Pipeline:

Facial Analysis
      ↓
Structured Findings
      ↓
Medical Safety Agent
      ↓
PASS / WARN / MODIFY / BLOCK / ESCALATE

⸻

44. Safety Output

Possible safety statuses:

PASS
CAUTION
MEDICAL_REVIEW_RECOMMENDED
BLOCK
URGENT_ESCALATION

⸻

45. Diagnosis Restriction

Unless explicitly validated and clinically governed:

Facial Analysis ≠ Diagnosis

This must remain a core product invariant.

⸻

46. Treatment Recommendation Restriction

Facial Analysis alone should not directly prescribe:

Medication
Dose
Treatment Schedule
Injection Volume
Injection Site
Surgical Procedure

⸻

47. Educational Guidance

The system may provide educational guidance.

Example:

The image shows visible uneven pigmentation.
Several different causes can produce similar visual appearances.
A clinician can determine the underlying cause during an examination.

⸻

48. Treatment Education

The system may explain categories of professional treatment.

Example:

Depending on the underlying cause, clinicians may consider options such as:
- topical therapies
- procedural treatments
- laser-based approaches
- other clinic-approved interventions

The exact recommendation should require appropriate clinical context.

⸻

49. Patient Autonomy

Facial Analysis must not pressure patients into treatment.

Avoid:

You need this treatment.

Prefer:

A clinician can assess whether treatment is appropriate for your goals.

⸻

50. Conversion Safety

Facial Analysis may support lead generation, but:

Conversion

must never override:

Safety
Truth
Uncertainty
Patient Autonomy

⸻

51. Lead Integration

Facial Analysis may generate behavioral signals such as:

Service Interest
Analysis Requested
Treatment Interest
Follow-Up Requested

The Lead Intelligence Agent should interpret these signals.

Facial Analysis should not directly determine:

HOT_LEAD

without the appropriate lead logic.

⸻

52. Patient Intelligence Integration

Facial Analysis may contribute structured observations to Patient Intelligence.

Example:

Patient
   ↓
Facial Analysis
   ↓
Visible Findings
   ↓
Patient Profile

Only appropriate and validated information should persist.

⸻

53. Patient Memory

Long-term memory should not store every raw model output.

Only validated, useful, and appropriately governed observations should become persistent patient memory.

⸻

54. Analysis History

Each analysis should be stored as an immutable or versioned analytical event.

Example:

Analysis 001
Analysis 002
Analysis 003

This enables longitudinal comparison.

⸻

55. Before/After Analysis

Clinicos should support comparison between two or more analyses.

Example:

Baseline
   ↓
Treatment
   ↓
Follow-Up
   ↓
Comparison

⸻

56. Before/After Requirements

Reliable comparison requires:

Similar Lighting
Similar Angle
Similar Distance
Similar Camera
Similar Expression
Minimal Makeup Differences

If these differ substantially, comparison confidence must decrease.

⸻

57. Comparison Output

Possible outputs:

Improved Appearance
No Significant Visible Change
Change Detected
Comparison Unreliable

⸻

58. No Guaranteed Treatment Effect

The system must not claim:

Treatment definitely caused the improvement.

unless the clinical workflow provides sufficient evidence.

Prefer:

A visible difference was detected between the provided images.

⸻

59. Longitudinal Tracking

The system may track trends such as:

Visible Texture
Visible Pigmentation
Visible Redness
Visible Lines

over time.

⸻

60. Trend Representation

Example:

{
  "feature": "visible_texture",
  "trend": "improved",
  "confidence": 0.74
}

⸻

61. Longitudinal Limitations

Changes in:

Lighting
Camera
Makeup
Skin Hydration
Expression
Angle

may create apparent changes unrelated to treatment.

These factors must be considered.

⸻

62. Standardized Photography

Clinicos should eventually support standardized capture guidance.

Recommended:

Front
Left Profile
Right Profile
45-Degree Left
45-Degree Right

depending on the analysis mode.

⸻

63. Capture Guidance

The patient should receive simple instructions before uploading.

Example:

Use natural or evenly distributed light.
Remove beauty filters.
Keep your face relaxed.
Keep the camera at eye level.
Keep your full face visible.

⸻

64. Standardization Metadata

Store where possible:

Image Angle
Capture Timestamp
Camera Metadata if Available
Analysis Mode
Capture Instructions
Quality Score

⸻

65. Image Metadata Privacy

EXIF metadata may contain sensitive information.

The system should remove or minimize unnecessary metadata where appropriate.

⸻

66. Image Storage

Original images should be stored securely.

Possible storage:

Object Storage
Encrypted Storage
Private Bucket

The database should normally store metadata and references rather than large binary image data.

⸻

67. Image Encryption

Sensitive images should be protected:

In Transit
At Rest
During Access

⸻

68. Image Access Control

Image access must enforce:

Tenant
Patient
Role
Permission
Purpose

⸻

69. Patient Image Isolation

Patient images must never become visible to another patient.

Cross-tenant image access must be impossible through normal application paths.

⸻

70. Image URLs

Prefer short-lived signed URLs or equivalent controlled access mechanisms.

Do not expose permanent public image URLs for sensitive patient images.

⸻

71. Image Retention

Retention should be configurable.

Possible policies:

Analysis Images:
Retain according to clinic policy.
Temporary Processing Images:
Delete after processing.
Failed Uploads:
Delete after appropriate retention period.

⸻

72. Image Deletion

When a patient image is deleted, the system should consider:

Original Image
Thumbnails
Derived Images
Analysis Artifacts
Caches
Temporary Files
Exports

⸻

73. Derived Data

Facial landmarks, embeddings, segmentation maps, and other derived representations may also be sensitive.

They must receive appropriate privacy controls.

⸻

74. Face Embeddings

Face embeddings can represent biometric information.

Clinicos must not treat them as ordinary analytics data.

If biometric representations are used, they require stronger security, governance, retention, and legal review.

⸻

75. Avoid Unnecessary Biometrics

Clinicos should avoid creating persistent facial identity embeddings unless they are necessary for an explicitly approved feature.

For many use cases, identity can be handled through patient/account context rather than biometric identification.

⸻

76. Face Recognition

Facial recognition should not be assumed as a default capability.

Facial analysis and facial identification are separate systems.

Facial Analysis
≠
Facial Recognition

⸻

77. Identity Binding

An uploaded image should be associated with the authenticated patient or authorized workflow.

Identity should come from:

Authenticated Session
Patient Context
Explicit User Selection

rather than facial recognition by default.

⸻

78. Model Architecture

The implementation may use specialized computer vision models.

Possible components:

Face Detector
Landmark Model
Segmentation Model
Feature Classifier
Quality Model
Comparison Model

Models should remain replaceable.

⸻

79. Model Provider Abstraction

Computer vision providers should use an abstraction layer.

Conceptually:

FacialAnalysisProvider
        ↓
Provider A
Provider B
Provider C
Local Model
Cloud Model

This prevents vendor lock-in.

⸻

80. AI Gateway Separation

The general LLM gateway and computer vision pipeline should remain logically distinct.

LLM Gateway

handles language models.

Vision Pipeline

handles image analysis.

They may interact through structured outputs.

⸻

81. Multimodal Models

A multimodal LLM may assist with interpretation.

However, it should not automatically replace specialized computer vision components when deterministic measurements or validated models are more appropriate.

⸻

82. Vision + LLM Architecture

Preferred:

Image
  ↓
Vision Models
  ↓
Structured Findings
  ↓
LLM Explanation
  ↓
Safety Validation
  ↓
Final Response

rather than:

Image
  ↓
LLM
  ↓
Everything

⸻

83. Structured Vision Output

Vision models should produce structured outputs.

Example:

{
  "quality": {
    "score": 0.91,
    "status": "good"
  },
  "regions": [
    {
      "name": "left_cheek",
      "observations": [
        {
          "type": "visible_pigmentation",
          "confidence": 0.83
        }
      ]
    }
  ]
}

⸻

84. Free-Form Vision Output

Free-form model output should not directly drive business logic.

Business logic should consume structured validated fields.

⸻

85. Validation Layer

Every vision result should pass through validation.

Validate:

Schema
Ranges
Required Fields
Confidence
Region Names
Allowed Categories
Model Version
Tenant Context

⸻

86. Impossible Output Detection

The system should reject impossible or malformed results.

Example:

confidence = 14.7

is invalid if the expected range is:

0.0 - 1.0

⸻

87. Model Versioning

Every analysis should record:

model_name
model_version
provider
pipeline_version
prompt_version
analysis_timestamp

where applicable.

⸻

88. Reproducibility

A facial analysis should be traceable to:

Image Version
Model Version
Pipeline Version
Configuration
Prompt Version if applicable

⸻

89. Analysis Immutability

Historical analysis results should not be silently overwritten.

If re-analysis occurs:

Analysis V1
Analysis V2

should remain distinguishable.

⸻

90. Re-Analysis

Re-analysis may occur because:

* model improved
* image quality changed
* pipeline changed
* clinician requested review
* previous analysis failed

The reason should be recorded.

⸻

91. Human Review

Human review should be supported.

A doctor or authorized clinician may:

Accept Observation
Reject Observation
Modify Observation
Add Observation
Add Comment
Mark for Follow-Up

⸻

92. Human Correction

Human corrections should be stored separately from original model outputs.

Example:

Model Observation:
Visible pigmentation
Clinician:
Confirmed
Final Clinical Record:
Confirmed by clinician

⸻

93. Human Review Authority

A clinician-confirmed finding may have higher authority than an unreviewed AI observation.

The exact authority hierarchy should be configurable.

⸻

94. Model Learning From Corrections

Human corrections may be used for future model evaluation or training.

However, they should not automatically update production model behavior.

Training workflows must remain controlled.

⸻

95. Dataset Governance

If facial images are used for model training or evaluation, the system must define:

Consent
Purpose
Retention
De-identification
Access
Usage Restrictions
Deletion

⸻

96. Consent

Patient consent requirements must be explicitly defined for:

Analysis
Storage
Long-Term Retention
Research
Model Improvement
Training
External Processing

These are not necessarily the same consent.

⸻

97. Consent Scope

A patient agreeing to:

"Analyze my image"

does not automatically imply permission for:

"Use my image to train future models."

⸻

98. Consent Recording

Consent records should contain:

consent_type
version
timestamp
actor
scope
status

⸻

99. Consent Revocation

If consent is revoked, applicable downstream workflows should respond according to policy.

⸻

100. External Vision Providers

If images are sent to an external AI provider:

The system must consider:

Provider Security
Data Retention
Data Processing
Geographic Processing
Privacy Terms
Consent
Contractual Requirements

⸻

101. Data Minimization

Only the minimum required image and metadata should be sent to external providers.

⸻

102. Provider Failure

If the vision provider fails:

VISION_PROVIDER_TIMEOUT
VISION_PROVIDER_ERROR
VISION_PROVIDER_UNAVAILABLE

the system should retry or safely report failure.

It must not fabricate an analysis.

⸻

103. Provider Routing

If multiple vision providers are available:

Provider Router

may select providers based on:

Capability
Availability
Cost
Latency
Accuracy
Privacy Requirements

⸻

104. Capability Routing

Different models may be specialized.

Example:

Quality Model
→ Image Quality
Landmark Model
→ Geometry
Skin Model
→ Visible Skin Features
Multimodal Model
→ Explanation

The orchestrator should select only necessary components.

⸻

105. Cost Optimization

Facial Analysis can be computationally expensive.

Optimization may include:

Image Compression
Preprocessing
Caching
Model Selection
Resolution Optimization
Batching
Avoiding Duplicate Analysis

Quality must not be reduced below acceptable thresholds.

⸻

106. Duplicate Analysis Detection

If the same image has already been analyzed under the same configuration:

Reuse Existing Result

where safe and appropriate.

⸻

107. Image Hashing

A cryptographic hash may identify duplicate files.

Example:

sha256(image_bytes)

The hash is not an identity mechanism.

⸻

108. Perceptual Similarity

Perceptual similarity may be used cautiously to detect near-duplicate images.

This must not be used as a substitute for patient identity verification.

⸻

109. Analysis Queue

Image analysis may run asynchronously.

Example:

Upload
 ↓
Job Created
 ↓
Queue
 ↓
Vision Processing
 ↓
Validation
 ↓
Report

⸻

110. Synchronous Analysis

For low-latency workflows, lightweight analysis may run synchronously.

The system should choose execution mode based on:

Image Size
Model Complexity
Provider Latency
User Experience

⸻

111. Analysis Job States

Recommended states:

QUEUED
PROCESSING
VALIDATING
COMPLETED
FAILED
CANCELLED
REVIEW_REQUIRED

⸻

112. Retry Policy

Transient failures may be retried.

Permanent failures should not be retried indefinitely.

Use:

Retry Count
Backoff
Failure Classification
Dead Letter Handling

⸻

113. Idempotency

Image analysis jobs should support idempotency.

Repeated requests should not accidentally create uncontrolled duplicate analyses.

⸻

114. Analysis Cancellation

Users or authorized staff may cancel pending analysis jobs when appropriate.

⸻

115. Analysis Events

Useful events include:

FACIAL_ANALYSIS_REQUESTED
IMAGE_VALIDATED
IMAGE_REJECTED
ANALYSIS_STARTED
ANALYSIS_COMPLETED
ANALYSIS_FAILED
REVIEW_REQUESTED
REVIEW_COMPLETED
REPORT_GENERATED

⸻

116. Event Observability

Each event should include:

event_id
tenant_id
patient_id
analysis_id
timestamp
actor
status

Sensitive image content should not be placed directly in general event logs.

⸻

117. Analysis Audit Trail

Audit records should answer:

Who requested the analysis?
Which image was analyzed?
Which model was used?
What was detected?
Was a human involved?
What changed?
Who viewed the result?

⸻

118. Report Generation

Facial Analysis may generate a patient-friendly report.

Possible formats:

PDF
Web Report
In-App Summary

⸻

119. Patient Report Structure

Suggested report:

Analysis Overview
Image Quality
Visible Observations
Confidence / Limitations
General Educational Information
Recommended Professional Next Step

⸻

120. Clinician Report Structure

Suggested report:

Patient Information
Analysis Metadata
Image Quality
Region Map
Structured Findings
Confidence
Comparison With Previous Analysis
Model Metadata
Safety Flags
Clinician Review

⸻

121. Report Disclaimer

Reports should clearly state appropriate limitations.

Example:

This analysis is based on the provided image and is not a substitute for an in-person clinical examination.

⸻

122. Report Evidence

Where appropriate, each important observation should remain traceable to:

Image Region
Model
Confidence
Analysis Version

⸻

123. Visual Report

Future reports may include annotated images.

Examples:

Face Region Highlight
Observation Marker
Before/After Comparison
Measurement Overlay

Annotations must be clearly labeled as AI-generated or clinician-confirmed.

⸻

124. Annotation Safety

AI annotations must not visually imply certainty.

For example:

"Possible visible pigmentation"

is safer than:

"Melasma"

unless clinically confirmed.

⸻

125. Report Sharing

Reports may be shared with authorized recipients.

Sharing must enforce:

Permission
Expiration
Audit
Patient Consent where required

⸻

126. Report Access

Report access should be revocable when appropriate.

⸻

127. Analytics

Facial Analysis analytics may track:

Analysis Count
Failure Rate
Image Quality Failure Rate
Average Processing Time
Model Performance
Human Correction Rate

⸻

128. Clinical Analytics

Clinical analytics should not infer disease prevalence from unvalidated AI observations.

Data must be labeled according to its evidentiary status.

⸻

129. Bias

Facial analysis may be affected by:

Skin Tone
Age
Gender
Lighting
Camera
Makeup
Cultural Differences
Model Training Distribution

The system must evaluate performance across relevant populations.

⸻

130. Fairness Evaluation

Evaluation should consider:

Different Skin Tones
Different Age Groups
Different Facial Structures
Different Image Conditions
Different Languages

⸻

131. Bias Monitoring

Monitor for:

Higher False Positive Rate
Higher False Negative Rate
Lower Confidence
Unequal Performance

across relevant groups.

⸻

132. No Sensitive Attribute Inference

The system should not infer sensitive personal attributes from facial appearance unless explicitly required, legally appropriate, and clinically justified.

⸻

133. Gender Inference

Gender classification should not be a default feature.

If unnecessary for the clinical or operational task:

Do Not Infer

⸻

134. Age Estimation

Age estimation should not be treated as verified patient age.

The system should use the authenticated patient profile for actual age where appropriate.

⸻

135. Identity Recognition

Facial analysis must not silently become identity recognition.

Patient identity should be derived from secure application context.

⸻

136. Security Threats

Potential threats include:

Unauthorized Image Access
Cross-Tenant Access
Image Leakage
Prompt Injection Through Image Content
Malicious Upload
Model Manipulation
Data Exfiltration
Insecure Report Sharing

⸻

137. Malicious Image Handling

Uploaded images must be treated as untrusted input.

Validate:

File Type
File Size
Encoding
Content
Processing Limits

⸻

138. Image Processing Isolation

Heavy image processing may run in isolated workers or sandboxed environments.

This reduces the blast radius of malicious or malformed files.

⸻

139. Resource Limits

Set limits for:

Image Size
Resolution
Processing Time
Memory
CPU
Number of Images

⸻

140. Rate Limiting

Facial Analysis requests should be rate-limited.

Limits may differ by:

Patient
Clinic
Role
Plan
Feature
Time Window

⸻

141. Usage Limits

Future monetization may allow:

Free Analysis
Paid Analysis
Clinic Subscription Limits
Doctor Unlimited Analysis

Business rules must remain separate from the vision model.

⸻

142. Free Analysis Policy

If a free analysis is offered, the system should enforce:

Eligibility
Usage Count
Reset Policy
Tenant Scope
User Scope

deterministically.

⸻

143. Analysis Cost Tracking

Track:

Provider Cost
Model Cost
Processing Cost
Storage Cost
Report Cost

where measurable.

⸻

144. Facial Analysis and Pricing

Facial Analysis may be connected to pricing intelligence.

However:

Facial Analysis

should not automatically determine:

Treatment Price

unless an explicit clinic pricing model supports the calculation.

⸻

145. Treatment Recommendation Architecture

A future recommendation workflow may be:

Image Analysis
      ↓
Patient Goals
      ↓
Medical History
      ↓
Medical Safety
      ↓
Clinician Rules
      ↓
Approved Knowledge
      ↓
Treatment Options

This is significantly safer than:

Image
 ↓
Treatment

⸻

146. Doctor Approval

For high-impact treatment recommendations, clinician review may be required.

Possible state:

AI_DRAFT
    ↓
DOCTOR_REVIEW
    ↓
APPROVED

⸻

147. Recommendation Traceability

A recommendation should be traceable to:

Patient Goal
Image Observation
Clinical Context
Approved Knowledge
Safety Rules
Clinician Review if applicable

⸻

148. Treatment Safety

The system must consider contraindications and relevant patient context before presenting treatment-related recommendations.

⸻

149. Facial Analysis and Medical History

When authorized, analysis may be combined with:

Allergies
Medications
Previous Treatments
Known Conditions
Pregnancy Status where relevant
Previous Adverse Reactions

However, sensitive patient data must be handled according to authorization and privacy policies.

⸻

150. Data Minimization

Only information necessary for the specific analysis should be loaded into the context.

⸻

151. Context Construction

The analysis context may contain:

Patient Goal
Image Findings
Image Quality
Relevant Patient Context
Approved Knowledge
Safety Rules
Previous Analysis

⸻

152. Context Priority

Priority should be:

System Safety
>
Medical Safety Rules
>
Authoritative Patient Data
>
Clinician-Confirmed Findings
>
Validated Image Findings
>
Approved Knowledge
>
AI Inference

⸻

153. Inference Labeling

The system should distinguish:

OBSERVED
CONFIRMED
INFERRED
POSSIBLE
UNKNOWN

⸻

154. Example Structured Finding

{
  "type": "visible_pigmentation",
  "region": "right_cheek",
  "status": "observed",
  "confidence": 0.82,
  "clinician_confirmed": false
}

⸻

155. Unknown Findings

The system should support:

UNKNOWN

as a valid output.

Unknown is preferable to unsupported certainty.

⸻

156. Analysis Explanation

The LLM explanation layer should only use structured findings and approved context.

It should not invent observations that are absent from the structured vision output.

⸻

157. Explanation Validation

Before returning an explanation:

Generated Claims
        ↓
Compare With Structured Findings
        ↓
Remove Unsupported Claims
        ↓
Medical Safety Review

⸻

158. Hallucination Prevention

The system must prevent:

Vision Model:
No lesion detected.
LLM:
A suspicious lesion is present.

Such contradictions must be detected or prevented.

⸻

159. Vision-Text Consistency

The explanation layer should be validated against:

Structured Vision Output

before delivery.

⸻

160. Model Disagreement

If multiple vision models disagree:

Model A:
Pigmentation
Model B:
No pigmentation

the system should:

Lower Confidence
Request Human Review
Return Uncertain

depending on risk.

⸻

161. Ensemble Models

Multiple models may be used for high-value analysis.

Possible architecture:

Model A
Model B
Model C
   ↓
Consensus / Calibration
   ↓
Final Finding

⸻

162. Ensemble Limitations

Model agreement does not automatically prove clinical truth.

Ensemble output remains subject to validation.

⸻

163. Analysis Evaluation Dataset

A representative dataset should include:

Different Skin Tones
Different Ages
Different Lighting
Different Cameras
Different Image Angles
Different Skin Conditions
Different Makeup Levels
Different Image Quality

⸻

164. Ground Truth

Ground truth should be defined appropriately.

For purely visual tasks:

Expert-Labeled Observation

may be sufficient.

For clinical diagnosis tasks:

Clinical Examination
Dermatologist Assessment
Histopathology where appropriate

may be required.

⸻

165. Model Metrics

Potential metrics:

Precision
Recall
F1
Sensitivity
Specificity
AUROC
Calibration
False Positive Rate
False Negative Rate

The correct metric depends on the task.

⸻

166. Safety-Critical Metrics

For high-risk findings, prioritize:

Sensitivity
False Negative Rate
Calibration
Escalation Reliability

rather than simple overall accuracy.

⸻

167. Quality Gate

A model should not be deployed solely because:

Accuracy is High

It must also satisfy:

Safety
Calibration
Fairness
Reliability
Latency
Cost
Privacy

requirements.

⸻

168. Model Regression

After any model change:

New Model
 ↓
Benchmark Dataset
 ↓
Safety Tests
 ↓
Bias Tests
 ↓
Comparison
 ↓
Approval

⸻

169. Canary Deployment

New models may initially run in:

Shadow Mode

or:

Canary Mode

before full rollout.

⸻

170. Shadow Mode

In shadow mode:

Production Model

continues to determine user-facing output.

The new model runs in parallel for evaluation.

⸻

171. Rollback

If a new model causes:

Accuracy Degradation
Safety Regression
Cost Spike
Latency Spike
Privacy Issue

the system must support rollback.

⸻

172. Model Registry

The system should maintain metadata for each production vision model:

model_id
version
provider
capabilities
status
approved_at
evaluation_results

⸻

173. Prompt Versioning

If an LLM is used for image interpretation or explanation, prompt versions should be tracked.

⸻

174. Pipeline Versioning

The complete facial analysis pipeline should have a version.

Example:

facial_pipeline_v1.4

⸻

175. Configuration Versioning

Thresholds should be versioned.

Examples:

Image Quality Threshold
Confidence Threshold
Escalation Threshold

⸻

176. Feature Flags

New analysis capabilities should be deployable behind feature flags.

Examples:

FACIAL_ANALYSIS_ENABLED
BEFORE_AFTER_ENABLED
ADVANCED_SKIN_ANALYSIS_ENABLED
REPORT_GENERATION_ENABLED

⸻

177. Tenant-Level Feature Flags

Different clinics may have different enabled capabilities.

Tenant configuration must be isolated.

⸻

178. Analysis Availability

The system should clearly communicate:

Feature Available
Feature Temporarily Unavailable
Analysis Failed
Analysis Requires Better Image
Analysis Requires Human Review

⸻

179. User Experience

The analysis workflow should minimize unnecessary friction.

Preferred flow:

Choose Analysis
      ↓
Upload Image
      ↓
Quality Check
      ↓
Retry if Needed
      ↓
Analyze
      ↓
Results
      ↓
Next Step

⸻

180. Progress Feedback

For asynchronous analysis:

Uploading
Checking Image
Analyzing
Preparing Results

should be visible.

⸻

181. Failure UX

Errors should be understandable.

Avoid:

VISION_ERR_502

for patients.

Prefer:

We could not complete the image analysis.
Please try again with a clearer photo.

⸻

182. Retry UX

The retry action should preserve the patient’s workflow where appropriate.

⸻

183. Analysis Result UX

Results should be organized:

Overall Summary
Image Quality
Visible Findings
Confidence
Limitations
Professional Next Step

⸻

184. Avoid Fear-Based UX

The system should avoid alarming language based solely on uncertain image observations.

⸻

185. Avoid False Reassurance

It should also avoid:

Everything is normal.

when the system cannot reliably establish that.

Prefer:

No major visible issue was detected in this image, but image analysis cannot rule out conditions that require clinical examination.

when appropriate.

⸻

186. Patient Questions

After analysis, users may ask:

What does this mean?
What can I do?
Is this dangerous?
What treatment is available?
How much does treatment cost?
Can I book an appointment?

These should route through:

Conversation Agent
Knowledge Agent
Medical Safety Agent
Pricing Agent
Appointment Agent

as appropriate.

⸻

187. Agent Routing Example

Patient:
"What is this redness?"
        ↓
Conversation Agent
        ↓
Knowledge Agent
        ↓
Medical Safety Agent
        ↓
Response

⸻

188. Appointment Conversion

If the patient wants professional assessment:

Facial Analysis
      ↓
Patient Interest
      ↓
Lead Intelligence
      ↓
Appointment Agent

The Appointment Agent must use authoritative availability.

⸻

189. Appointment Confirmation

Facial Analysis must never claim:

Your appointment is booked.

unless the Appointment Agent confirms successful booking.

⸻

190. Follow-Up

After analysis, follow-up may be triggered according to workflow rules.

Examples:

Analysis Completed
No Appointment Yet
Patient Expressed Interest

The Follow-up Engine may create a task or message.

⸻

191. Follow-Up Safety

Follow-up content must use:

Approved Knowledge
Current Clinic Policy
Patient Context
Safety Rules

⸻

192. Analytics Events

Track meaningful events:

ANALYSIS_STARTED
ANALYSIS_COMPLETED
ANALYSIS_RETRIED
ANALYSIS_FAILED
REPORT_VIEWED
APPOINTMENT_REQUESTED
HUMAN_REVIEW_REQUESTED

⸻

193. Funnel Metrics

Potential metrics:

Upload Rate
Successful Analysis Rate
Retry Rate
Analysis Completion Rate
Result View Rate
Appointment Intent Rate
Booking Rate

⸻

194. Funnel Interpretation

Analytics must distinguish:

Observed Event

from:

AI Interpretation

⸻

195. Reporting

Clinic reports may include:

Number of Analyses
Average Image Quality
Failure Rate
Human Review Rate
Popular Analysis Types
Conversion After Analysis

⸻

196. Medical Reporting Boundaries

Operational reports must not present unvalidated AI observations as clinical epidemiology.

⸻

197. Data Export

Authorized staff may export:

Analysis Metadata
Reports
Clinician Notes

according to permissions.

Raw images require stronger access control.

⸻

198. Export Audit

Exports should be logged.

⸻

199. Data Portability

Patient-related analysis data should be exportable or retrievable according to applicable privacy and retention policies.

⸻

200. Deletion Propagation

Deletion requests should propagate to:

Original Image
Derived Image
Analysis Result
Annotations
Embeddings
Temporary Files
Reports
Caches

where applicable.

⸻

201. Security Testing

Test:

Cross-Tenant Image Access
Cross-Patient Image Access
Unauthorized Report Access
Signed URL Abuse
Deleted Image Retrieval
Malicious Upload
Prompt Injection Through Image

⸻

202. Privacy Testing

Test:

Consent Enforcement
Consent Revocation
Retention Enforcement
Deletion Propagation
Export Authorization
Provider Data Handling

⸻

203. Medical Safety Testing

Test:

Unsafe Diagnosis
False Reassurance
Unsupported Treatment
Unsupported Medication
Missed Escalation
Over-Escalation
Contradictory Findings
Low-Confidence Findings

⸻

204. Image Quality Testing

Test:

Blurred Image
Dark Image
Overexposed Image
Side Profile
Partial Face
Multiple Faces
Heavy Makeup
Beauty Filter
Occlusion
Low Resolution

⸻

205. Robustness Testing

Test across:

Different Phones
Different Cameras
Different Lighting
Different Skin Tones
Different Ages
Different Facial Structures

⸻

206. Performance Testing

Measure:

Upload Time
Preprocessing Time
Model Inference Time
LLM Time
Total Analysis Time

⸻

207. Cost Testing

Measure:

Average Cost per Analysis
Provider Cost
Storage Cost
Report Cost
Retry Cost

⸻

208. Reliability

Target reliability should include:

High Successful Analysis Rate
Low Unexpected Failure Rate
Safe Retry
Correct Job State
No Duplicate Billing
No Duplicate Analysis

⸻

209. Idempotent Billing

If analysis is monetized, retrying the same analysis must not accidentally create multiple charges.

⸻

210. Usage Accounting

Usage counters should be updated transactionally.

⸻

211. Analysis Ownership

Every analysis should belong to:

Tenant
Patient
Requester

and optionally:

Conversation
Appointment
Treatment Journey

⸻

212. Analysis Relationships

Possible relationships:

Patient
 ├── Analysis
 ├── Appointment
 ├── Treatment
 └── Follow-Up

⸻

213. Treatment Journey

A future treatment journey may contain:

Consultation
Baseline Image
Treatment
Follow-Up Image
Comparison
Clinician Review
Outcome

⸻

214. Outcome Tracking

If appropriate, outcomes may be tracked separately from AI analysis.

Example:

AI:
Visible improvement detected.
Patient:
Satisfied.
Clinician:
Improvement confirmed.

These are different signals.

⸻

215. Patient Satisfaction

Patient satisfaction should not be inferred solely from image improvement.

⸻

216. Clinician Confirmation

Clinician confirmation may be represented separately:

{
  "finding": "visible_pigmentation",
  "ai_status": "observed",
  "clinician_status": "confirmed"
}

⸻

217. Analysis Confidence and Human Review

Lower confidence should increase the probability of human review for relevant workflows.

⸻

218. Review Thresholds

Different categories may have different thresholds.

Example:

Low-Risk Cosmetic Observation
→ Lower Review Requirement
Potential Medical Concern
→ Higher Review Requirement

⸻

219. Human-in-the-Loop Architecture

AI Analysis
    ↓
Risk Classification
    ↓
Automatic Result
or
Human Review
    ↓
Final Result

⸻

220. Human Review SLA

Future clinics may configure review expectations.

Example:

HIGH_RISK_REVIEW
→ Priority
NORMAL_REVIEW
→ Standard Queue

⸻

221. Escalation Queue

The system should provide a clinician review queue.

Possible filters:

High Risk
Low Confidence
Patient Requested Review
Model Disagreement
Potential Safety Issue

⸻

222. Review Notifications

Authorized clinicians may receive notifications for:

Urgent Review
New Review
Repeated Patient Concern

⸻

223. AI Transparency

Patient-facing analysis should communicate that:

AI-assisted analysis

was used.

The exact wording may depend on clinic policy and jurisdiction.

⸻

224. Explainability

The system should be able to explain:

What was observed
Where it was observed
How confident the system was
What limitations exist

It should not fabricate internal model reasoning.

⸻

225. No Fake Explainability

Do not claim:

The model saw X because of hidden feature Y

unless the system has validated evidence for that explanation.

⸻

226. Evidence-Based Explanation

Use observable evidence:

The system detected increased visible color variation in the cheek region.

rather than invented internal reasoning.

⸻

227. Facial Analysis Knowledge

The Knowledge System may provide educational content about:

Skin Features
Treatment Categories
Aftercare
Preparation
Clinic Services

The Knowledge System does not validate the image itself.

⸻

228. Facial Analysis + RAG

Preferred architecture:

Image
 ↓
Vision
 ↓
Structured Findings
 ↓
Knowledge Retrieval
 ↓
Medical Safety
 ↓
LLM Explanation

⸻

229. RAG Restrictions

The LLM must not use general medical knowledge to invent image findings.

RAG provides contextual knowledge, not visual evidence.

⸻

230. Tool Boundaries

Possible tools:

analyze_image
get_patient_context
get_approved_knowledge
get_clinic_service
get_current_price
get_appointment_availability
create_review_task
generate_report

Each tool requires explicit authorization.

⸻

231. Facial Analysis Agent

The Facial Analysis Agent should coordinate:

Image Processing
Structured Findings
Confidence
Comparison
Safety Handoff

It should not independently control appointment or pricing workflows.

⸻

232. Agent Contract

Conceptual input:

{
  "patient_id": "...",
  "analysis_mode": "skin_analysis",
  "image_id": "...",
  "goal": "understand_visible_skin_features"
}

Conceptual output:

{
  "status": "completed",
  "quality": {...},
  "findings": [...],
  "limitations": [...],
  "safety_status": "pass"
}

⸻

233. Agent Failure

Possible failures:

INVALID_IMAGE
LOW_IMAGE_QUALITY
VISION_UNAVAILABLE
ANALYSIS_TIMEOUT
MODEL_ERROR
VALIDATION_ERROR
SAFETY_REVIEW_REQUIRED

⸻

234. Recovery

Recovery may include:

Retry
Alternative Provider
Request Better Image
Human Review
Safe Failure

⸻

235. No Fabricated Recovery

If the vision provider fails:

Do Not Guess

The system should clearly report inability to complete the analysis.

⸻

236. Multilingual Results

Patient-facing results should support:

Persian
English
Azerbaijani Turkish
Arabic
Turkish

The underlying structured findings should remain language-neutral.

⸻

237. Translation

Structured labels should be translated at the presentation layer where practical.

Example:

Internal:
visible_pigmentation

may render differently by language.

⸻

238. Medical Terminology

Medical terminology should be handled carefully.

Patient-facing language should prioritize understandable explanations.

Clinician-facing language may use appropriate medical terminology where validated.

⸻

239. Language Consistency

Numbers, units, anatomical regions, and uncertainty should remain semantically consistent across translations.

⸻

240. Localization

Localization may include:

Language
Date Format
Units
Currency
Clinic Terminology

⸻

241. Facial Analysis Data Model

A conceptual analysis entity may contain:

analysis_id
tenant_id
patient_id
requester_id
image_id
analysis_mode
status
quality_score
model_version
pipeline_version
created_at
completed_at

⸻

242. Observation Entity

A conceptual observation entity may contain:

observation_id
analysis_id
region
category
value
severity
confidence
status
source
model_version
clinician_confirmed
created_at

⸻

243. Review Entity

A conceptual review entity may contain:

review_id
analysis_id
reviewer_id
status
decision
comment
created_at
completed_at

⸻

244. Image Entity

A conceptual image entity may contain:

image_id
tenant_id
patient_id
storage_reference
mime_type
size
width
height
sha256
quality_status
created_at
deleted_at

⸻

245. Consent Entity

A conceptual consent entity may contain:

consent_id
patient_id
consent_type
version
status
granted_at
revoked_at

⸻

246. Report Entity

A conceptual report entity may contain:

report_id
analysis_id
format
storage_reference
version
created_at
expires_at

⸻

247. Database Principles

Facial analysis data should follow:

Tenant Isolation
Referential Integrity
Auditability
Versioning
Soft Deletion Where Required
Retention Policies

⸻

248. Raw Image Storage

Raw image binaries should generally remain outside the primary relational database unless there is a specific reason to store them there.

⸻

249. Object Storage References

The relational database should store:

Storage Provider
Object Key
Encryption Metadata
Content Type
Checksum

where appropriate.

⸻

250. Database Transactions

Critical operations such as:

Create Analysis
Create Usage Record
Create Job

should maintain consistency.

⸻

251. Queue Consistency

If a database record says:

PROCESSING

but no queue job exists, the system should detect and recover from the inconsistency.

⸻

252. Orphaned Job Detection

Background monitoring should detect:

Stuck Jobs
Failed Jobs
Missing Jobs
Duplicate Jobs

⸻

253. Storage Failure

If image upload succeeds but metadata creation fails:

Recovery
Cleanup
Retry

must prevent orphaned sensitive files.

⸻

254. Cleanup Jobs

Periodic cleanup may remove:

Expired Temporary Files
Failed Uploads
Expired Reports
Expired Derived Artifacts

according to retention policy.

⸻

255. Observability

Metrics should include:

analysis_requests_total
analysis_success_total
analysis_failure_total
analysis_latency
image_quality_failure_rate
provider_failure_rate
review_rate

⸻

256. Logging

Logs should avoid unnecessary:

Raw Images
Sensitive Patient Data
Full Medical Notes

⸻

257. Trace IDs

Each analysis should have a traceable request ID.

Example:

request_id
analysis_id
job_id

⸻

258. Distributed Tracing

If multiple services are involved:

API
 ↓
Queue
 ↓
Vision Worker
 ↓
Validation
 ↓
LLM
 ↓
Safety
 ↓
Report

trace context should be preserved.

⸻

259. Alerting

Alerts may trigger on:

Provider Failure Spike
Analysis Failure Spike
Unexpected Cost Spike
Latency Spike
Safety Escalation Spike
Unauthorized Access
Storage Failure

⸻

260. Facial Analysis SLOs

Future SLOs may define:

Availability
Latency
Success Rate
Review SLA

based on analysis type.

⸻

261. Deployment

Vision workers should be deployable independently where practical.

⸻

262. Scaling

Scaling may depend on:

Image Queue Length
CPU
GPU
Provider Capacity
Request Rate

⸻

263. GPU Usage

If local models require GPU resources, the architecture should isolate GPU-dependent workloads from general application services where practical.

⸻

264. Provider Abstraction

The system should allow:

Cloud Vision
Local Vision
Hybrid Vision

without changing the higher-level Agent contract.

⸻

265. Provider Selection

Provider routing may consider:

Privacy
Cost
Latency
Accuracy
Availability
Capability
Region

⸻

266. Privacy-First Routing

For highly sensitive workflows, the system may prefer local processing if available and sufficiently accurate.

⸻

267. Fallback Routing

If the primary provider fails:

Primary Provider
      ↓
Failure
      ↓
Fallback Provider

only if the fallback meets privacy and capability requirements.

⸻

268. No Unsafe Fallback

A cheaper or more available provider must not be used if it violates the workflow’s privacy or safety requirements.

⸻

269. Provider Health

Track:

Latency
Error Rate
Timeout Rate
Accuracy Signals
Cost
Availability

⸻

270. Model Cost Governance

The orchestrator should avoid expensive vision pipelines when a simpler validated analysis is sufficient.

⸻

271. Progressive Analysis

Possible strategy:

Basic Quality Check
      ↓
If Good
      ↓
Basic Analysis
      ↓
If Needed
      ↓
Advanced Analysis

This reduces unnecessary cost.

⸻

272. Patient Request Scope

The system should analyze only what the user requested when practical.

Example:

User asks about skin texture

does not necessarily require:

Full facial geometry analysis

⸻

273. Purpose Limitation

Analysis must have an explicit purpose.

Example:

Purpose:
Skin Texture Analysis

This improves:

Privacy
Cost
Safety
Explainability

⸻

274. Analysis Consent + Purpose

Consent and analysis purpose should remain linked where appropriate.

⸻

275. Data Lifecycle

Preferred lifecycle:

Upload
 ↓
Validate
 ↓
Analyze
 ↓
Store Result
 ↓
Use Result
 ↓
Retain According to Policy
 ↓
Delete / Archive

⸻

276. Lifecycle Audit

Lifecycle actions should be auditable for sensitive data.

⸻

277. Facial Analysis Definition of Done

A Facial Analysis capability is complete when:

[ ] Image upload validated
[ ] Image quality validated
[ ] Face detection implemented
[ ] Structured findings implemented
[ ] Confidence implemented
[ ] Safety integration implemented
[ ] Privacy controls implemented
[ ] Tenant isolation tested
[ ] Patient isolation tested
[ ] Human review supported where required
[ ] Model versioning implemented
[ ] Audit trail implemented
[ ] Error handling implemented
[ ] Evaluation dataset created
[ ] Bias evaluation completed
[ ] Security testing completed
[ ] Cost measured
[ ] Performance measured

⸻

278. Image Analysis Definition of Done

An image analysis pipeline is production-ready when:

[ ] Valid images accepted
[ ] Invalid images rejected
[ ] Poor-quality images detected
[ ] Multiple faces handled
[ ] Beauty filters considered
[ ] Structured output validated
[ ] Unsupported findings prevented
[ ] Provider failures handled
[ ] Results traceable
[ ] Results reproducible

⸻

279. Medical Safety Definition of Done

Medical safety integration is complete when:

[ ] High-risk findings identified
[ ] Diagnostic overclaiming prevented
[ ] Treatment overclaiming prevented
[ ] Escalation path implemented
[ ] Human review supported
[ ] Emergency boundaries defined
[ ] Safety regression tests added

⸻

280. Privacy Definition of Done

Privacy controls are complete when:

[ ] Consent model implemented
[ ] Image access control implemented
[ ] Tenant isolation tested
[ ] Patient isolation tested
[ ] Retention implemented
[ ] Deletion implemented
[ ] Derived data controlled
[ ] Provider data handling reviewed
[ ] Export audited

⸻

281. Model Definition of Done

A production model is approved when:

[ ] Benchmark completed
[ ] Calibration evaluated
[ ] Bias evaluated
[ ] Safety evaluated
[ ] Regression tests passed
[ ] Latency measured
[ ] Cost measured
[ ] Rollback available
[ ] Version registered

⸻

282. Final Safety Invariants

The following rules are mandatory:

No image analysis may be presented as definitive diagnosis unless explicitly validated and clinically governed.
No treatment recommendation may be generated solely from an image without appropriate context and safety controls.
No raw patient image may cross tenant boundaries.
No patient image may be exposed to another patient.
No AI-generated observation may silently become clinician-confirmed information.
No unsupported visual finding may be invented by the language model.
No failed vision provider may result in fabricated analysis.
No low-quality image may produce high-confidence conclusions.
No beauty filter or lighting artifact should be silently treated as a clinical finding.
No facial recognition should be introduced implicitly into facial analysis.
No biometric representation should be stored unnecessarily.
No patient image should be used for model training without appropriate consent and governance.
No conversion objective may override medical safety or patient autonomy.
No AI result should hide uncertainty when uncertainty materially affects the decision.

⸻

283. Final Architecture

The target architecture is:

                    ┌──────────────────────┐
                    │      Patient/User    │
                    └──────────┬───────────┘
                               │
                               ▼
                    ┌──────────────────────┐
                    │   Image Upload API   │
                    └──────────┬───────────┘
                               │
                               ▼
                    ┌──────────────────────┐
                    │   Image Validation   │
                    └──────────┬───────────┘
                               │
                               ▼
                    ┌──────────────────────┐
                    │   Quality Analysis   │
                    └──────────┬───────────┘
                               │
                               ▼
                    ┌──────────────────────┐
                    │   Vision Pipeline    │
                    │                      │
                    │ Face Detection       │
                    │ Landmarks            │
                    │ Regions              │
                    │ Skin Features        │
                    │ Geometry             │
                    └──────────┬───────────┘
                               │
                               ▼
                    ┌──────────────────────┐
                    │ Structured Findings  │
                    └──────────┬───────────┘
                               │
                ┌──────────────┴──────────────┐
                │                             │
                ▼                             ▼
      ┌──────────────────┐          ┌──────────────────┐
      │ Knowledge / RAG  │          │ Patient Context  │
      └────────┬─────────┘          └────────┬─────────┘
               │                             │
               └──────────────┬──────────────┘
                              │
                              ▼
                    ┌──────────────────────┐
                    │ Medical Safety Agent│
                    └──────────┬───────────┘
                               │
                               ▼
                    ┌──────────────────────┐
                    │ Explanation / LLM    │
                    └──────────┬───────────┘
                               │
                               ▼
                    ┌──────────────────────┐
                    │ Grounding Validation │
                    └──────────┬───────────┘
                               │
                               ▼
                    ┌──────────────────────┐
                    │ Human Review if Need │
                    └──────────┬───────────┘
                               │
                               ▼
                    ┌──────────────────────┐
                    │ Final Patient Result │
                    └──────────────────────┘

⸻

284. Final Product Philosophy

Facial Analysis should not be positioned as:

"AI that diagnoses your face."

The stronger and safer product concept is:

"AI-assisted visual analysis that helps patients and clinics understand visible findings, organize information, track changes, and connect observations to appropriate professional care."

⸻

285. Final Principle

The ultimate Facial Analysis principle for Clinicos is:

The image is evidence of what is visibly present in the image, not proof of what is medically true about the patient.

And:

Every visual observation must remain distinguishable from clinical diagnosis, clinical judgment, and treatment recommendation.

And:

When image quality, model confidence, or clinical risk is insufficient, Clinicos must prefer uncertainty, better input, or human review over false certainty.

And finally:

Facial Analysis should augment clinical expertise, improve patient understanding, and strengthen clinic workflows without pretending to replace professional medical judgment.
